-68%

est. 2Y upside i

HealthcareSeries B

Rank

#2492

Sector

Digital Health, AI in Healthcare

Est. Liquidity

~3Y

Data Quality

Data: Medium

Curai Health operates in a large and growing digital health market with a compelling AI-powered virtual care model and $35M in revenue.

Last updated: March 10, 2026

Bull (15%)+250%

Strong adoption of its AI-powered platform by new enterprise partners and payers, coupled with expanding direct-to-consumer reach, drives revenue to $150M+ by 2028, justifying a $1.2B+ valuation at 8x revenue as a leader in accessible virtual primary care.

Base (45%)+50%

Curai Health maintains its growth trajectory, securing additional mid-tier enterprise partnerships and expanding its subscription base, reaching ~$70M revenue by 2028, leading to an estimated $525M valuation at 7.5x revenue, reflecting steady execution in a competitive market.

Bear (40%)-60%

Intensified competition from well-funded incumbents and larger tech players, combined with slower-than-expected enterprise adoption, limits revenue growth to ~$45M by 2028, resulting in a down round or flat exit at a $140M valuation (4x revenue), significantly eroding common stock value due to liquidation preferences.

Est. time to liquidity~3.0 years

Preference Stack Risk

high

Investors hold $57M in liquidation preferences, representing 16.3% of the estimated $350M current valuation. In a downside scenario, this could significantly impact common stock returns.

Dilution Risk

high

As a Series B company (with its last round in 2020), Curai Health will likely require at least one or two more significant funding rounds (Series C, D) before an IPO or acquisition, leading to further dilution for current equity holders.

Secondary Liquidity

limited

While platforms like Nasdaq Private Market may facilitate secondary transactions for accredited investors, active secondary liquidity for all employees is likely limited for a company at this stage.

AI — 1 role

View all 7 open roles at Curai →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Curai's data — designed to show you've done your homework.

  • 1

    “Given the strong competition from established players like Amwell and Amazon's entry into virtual care, how does Curai Health plan to differentiate and capture significant market share over the next 2-3 years?”

  • 2

    “With $35M in revenue, what are the key growth levers the company is focusing on to scale to $100M+ ARR, particularly in terms of expanding enterprise partnerships and subscription base?”

  • 3

    “Considering the Series B was in 2020, what is the company's current thinking on the timeline for the next funding round or a potential liquidity event for employees?”

Community

Valuation Sentiment

Our model estimates -68% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.